These findings highlight RHOF, c-Myc, PKM2, and Snail1 as key components of a lactylation-related glycolytic axis in pancreatic cancer and suggest that this pathway may represent a potential target for therapeutic intervention, particularly in tumors with activated glycolysis (86). The gene discussed is MYC; the disease is familial pancreatic carcinoma.